- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mucopolysaccharidosis Type II (MPS II)
Total 2672 results
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type IIUnited States
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type IIUnited States
-
Carl T. Hayden VA Medical CenterSanofiCompletedDiabetes Mellitus, Type IIUnited States
-
AstraZenecaCompletedType II Diabetes MellitusSweden, Mexico, Peru, United Kingdom, Germany, Hungary, Latvia, Lithuania, Poland, Chile, Romania
-
East Carolina UniversityCompletedDiabetes Mellitus Type IIUnited States
-
Forest LaboratoriesPhenomixTerminatedDiabetes Mellitus, Type IIUnited States, Belarus, India, Romania, Germany, Lithuania
-
American Scitech InternationalProactive Clinical ResearchUnknownType II Diabetes MellitusUnited States, India
-
GenfitCompletedType II Diabetes MellitusBosnia and Herzegovina, Latvia, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Serbia
-
PfizerCompletedDiabetes Mellitus, Type IIBelgium
-
Center for Integrative Medicine, GermanyUnknownDiabetes Mellitus, Type IIGermany
-
AstraZenecaCompletedType II Diabetes MellitusUnited States
-
ECbiotech TaiwanCompletedThe Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)Diabetes Mellitus, Type IITaiwan
-
Aristotle University Of ThessalonikiUniversity of AthensCompletedType II Diabetes MellitusGreece
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Mountain Diabetes and Endocrine CenterCompletedDiabetes Mellitus, Type IIUnited States
-
Getz PharmaCompletedType II Diabetes MellitusPakistan
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType II Diabetes MellitusUnited States
-
Materia Medica HoldingCompletedType II Diabetes MellitusRussian Federation
-
Joslin Diabetes CenterMassachusetts Institute of TechnologyCompletedType II DiabetesUnited States
-
TakedaCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType II Diabetes MellitusKorea, Republic of
-
University of BolognaCompletedSiewert Type II Adenocarcinoma of Esophagogastric JunctionItaly
-
Hua Medicine LimitedCompletedType II Diabetes MellitusChina
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type II
-
Chong Kun Dang PharmaceuticalUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
PfizerCompletedDiabetes Mellitus, Type IIUnited States
-
Johns Hopkins Bloomberg School of Public HealthPatient-Centered Outcomes Research InstituteUnknownMeasuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst ScalingType II DiabetesUnited States
-
Medical University of ViennaCompletedDiabetes Mellitus Type IIAustria
-
BayerCompleted
-
ikfe-CRO GmbHNovartis Pharmaceuticals; IKFE Institute for Clinical Research and DevelopmentUnknown
-
Arizona State UniversityTakeda Pharmaceuticals North America, Inc.UnknownType II Diabetes MellitusUnited States
-
AstraZenecaCompletedType II Diabetes MellitusUnited States
-
Ferzli, George S., M.D. F.A.C.S.UnknownType II DiabetesUnited States
-
Hospices Civils de LyonCompleted
-
The Second Hospital of QinhuangdaoCompletedClosed Frykman Type II Fracture of Right Radial Head
-
Chong Kun Dang PharmaceuticalNot yet recruitingType II Diabetes Mellitus
-
Fractyl Health Inc.Completed
-
Global Preventive Medicine Biotech Co., Ltd.Completed
-
Riphah International UniversityCompletedType II Diabetes MellitusPakistan
-
Medical University of GrazCompletedDiabetes Mellitus, Type IIAustria
-
AstraZenecaCompletedType II Diabetes MellitusUnited Arab Emirates, Kuwait
-
Astellas Pharma IncTerminatedA Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusType II Diabetes MellitusTaiwan, Korea, Republic of